产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
首页 制药产品大全 食品添加剂 维生素K2

维生素K2

2026-02-26
清远市

产品详情

维生素K2
食品添加剂
5kg/bag
北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲

产品描述

CAS Number: 2124-57-4

Molecular Formula: C46H64O2

Formula Weight: 649.0

Purity: 1000ppm; 2000ppm; 2500ppm; 10000ppm; 13000ppm; 20000ppm

Fermentation: Bacillus subtilis natto

While Vitamin K2 MK-7 originates from fermentation, the quality of the fermentation process can vary significantly among different types of foods. Therefore, not all fermented foods are equally effective at providing sufficient levels of MK-7.

When it comes to Vitamin K2 density, particularly in MK-7, Natto, a fermented soy dish from Japan, is the clear winner. That is natto vitamin k2 mk7.

Natto Vitamin K2 MK7 activates osteocalcin, a protein that helps to build strong bones. It also helps to prevent calcium from accumulating in the arteries and other soft tissues, reducing the risk of cardiovascular disease.

Vitamin K2 plays a crucial role in maintaining cardiovascular health by regulating calcium balance. The impact of vitamin K2 on the cardiovascular system is achieved by activating matrix Gla protein, an anti-calcification protein. When in its inactive state, this protein is linked with various markers of cardiovascular disease such as increased arterial stiffness, insulin resistance, vascular and valvular calcification, and heart failure indicators, all of which contribute to higher cardiovascular mortality. By altering systemic calcification and arterial stiffness, vitamin K2 supplementation has been found to significantly improve cardiovascular outcomes. While the direct impact of vitamin K2 supplementation on the progression of vascular and valvular calcification is currently being investigated in several randomized clinical trials, previous studies indicate that vitamin K2 supplementation may enhance survival among cardiac patients. Because it is reasonably priced and has been proven safe by the FDA, vitamin K2 supplementation is a promising option to promote better cardiovascular outcomes.

广东新达瑞生物科技有限公司
访问店铺
注册资本
公司地址
联系人

公司简介

广东新达瑞生物科技有限公司是一家研发驱动型高科技生物制药企业,致力于原创性新药及其核心中间体、高端原料药及其核心中间体的研发和商业化生产。公司符合美国FDA、欧盟EUGMP的质量管理要求,实践国际标准的药品质量管理规范和严格的药品生产管理体系,确保产品质量。 新达瑞生物积极实施人才战略,拥有生物制药行业高层次管理人才和技术团队,从而确保公司在生物制药领域有顽强的生命力和卓越的竞争力。 新达瑞生物以高效、环保、优质为原则,立足中国,放眼国际,以行业标杆要求自己,打造国际一流的生物医药供应商!
业务类型:
成立日期:
年营业额:
主营产品类别: